Primellose®

Croscarmellose sodium 

Fast water-uptake and rapid swelling

Excellent disintegration performance in various processes

Oral Solid Dose
Primellose

Product information

Primellose® is DFE Pharma’s product brand name for croscarmellose sodium. It is manufactured in a dedicated pharmaceutical plant in Foxhol, The Netherlands. Primellose® croscarmellose sodium is suitable for various tablet and capsule formulations. Primellose® is effective in combination with both insoluble and soluble filler-binders at concentrations of 2%w/w - 6%w/w. Primellose® is effective in both direct compression and dry/wet granulation, where it is used both intragranularly and/or extragranularly. 

Product types
Croscarmellose sodium
Excipient functionality
Disintegrant
Recommended process
Direct compression, Dry blending, Dry granulation, Wet granulation
Dosage forms
Tablet, Capsule (Oral Solid Dose), Orally disintegrating tablet

Typical product data

Source

Source
Cotton cellulose

pH

pH
6.6

Disintegration mechanism

Disintegration mechanism
Wicking and swelling

Documentation

  • ALBA Primellose
  • Oral Solid Dose Brochure View
  • Contaminants statement Primellose
  • ICHQ3D - Elemental Impurities Superdisintegrants
  • Kosher DFE Foxhol
  • Nutritional information Primellose
  • GMO Statement Primellose
  • Ingredient declaration Primellose
  • MSDS Primellose